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a b s t r a c t
Previous research has found that a common polymorphism in the serotonin transporter gene (5-
HTTLPR) is an important mediator of individual differences in brain responses associatedwith emotional
behaviour. In particular, relative to individuals homozygous for the l-allele, carriers of the s-allele display
heightened amygdala activation to emotional compared to non-emotional stimuli. However, there is
some debate as to whether this difference is driven by increased activation to emotional stimuli, resting
baseline differences between the groups, or decreased activation to neutral stimuli. We performed func-
tional imaging during an implicit facial expression processing task in which participants viewed angry,
sad and neutral faces. In addition to neutral faces, we included two further baseline conditions, houses
and ﬁxation. We found increased amygdala activation in s-allele carriers relative to l-homozygotes in
response to angry faces compared to neutral faces, houses and ﬁxation.When comparing neutral faces to
houses or ﬁxation, we found no signiﬁcant difference in amygdala response between the two groups. In
addition, there was no signiﬁcant difference between the groups in response to ﬁxation when compared
with a houses baseline. Overall, these results suggest that the increased amygdala response observed in
s-allele carriers to emotional faces is primarily driven by an increased response to emotional faces rather
than a decreased response to neutral faces or an increased resting baseline. The results are discussed in
relation to the tonic and phasic hypotheses of 5-HTTLPR-mediated modulation of amygdala activity.
© 2010 Elsevier Ltd. Open access under CC BY license.
1. Introduction
Serotonin is a fundamental neuromodulator within brain
regions involved in emotional behaviour such as the amygdala
(Hariri & Holmes, 2006). Abnormalities in the serotonergic sys-
tem have been found in individuals with mood, anxiety and
aggressive disorders, and treatment of these psychiatric conditions
often involves pharmacological manipulation of the serotonergic
system (Ballenger, 1999; Blier & de Montigny, 1999). In recent
years there has been considerable interest in determining possible
genetic factors underlying the regulation of serotonin levels, and
whether individual differences in temperament and vulnerability
to emotional disorders might reﬂect variation in the expression of
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serotonergic genes. A candidate gene that has been studied exten-
sively in this context is the serotonin transporter (5-HTT) gene
(SLC6A4). Lesch et al. (1996) found that a common genetic vari-
ation in the transcription region (5-HTTLPR) of this gene, which
consists of short- (s-) and long- (l-) allele variants, results in differ-
ential expression of 5-HTT, with the s-allele variant expressing less
5-HTT protein than the l-allele.
Individuals who carry at least one copy of the s-allele have been
associatedwithhaving increased levels of anxiety, reduced capabil-
ity to deal with stress, and thus greater susceptibility to depression
in the context of stressful life events (Caspi et al., 2003; Caspi,
Hariri,Holmes,Uher,&Mofﬁtt, 2010). Furthermore, functionalneu-
roimaging studies have consistently identiﬁed the amygdala as
a key brain region where the s-allele genotype exerts its effects.
Hariri et al. (2002) were the ﬁrst to report that, relative to individ-
uals homozygous for the l-allele, carriers of the s-allele displayed
heightened amygdala activation to fearful and angry facial expres-
sions compared with non-emotional stimuli, suggesting that the
0028-3932/© 2010 Elsevier Ltd. Open access under CC BY license. 
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5-HTT polymorphism is implicated in the modulation of affective
behaviour through the amygdala. The differential activation of the
amygdala to emotional stimuli in carriers of the s-allele has since
been replicated in several independent studies using similar tasks
(Munafo, Brown, & Hariri, 2008), as well as in studies using a vari-
ety of other types of emotional stimuli including negative words
(Canli et al., 2005), aversive pictures (Heinz et al., 2005), and sub-
liminally presented sad emotional facial expressions (Dannlowski
et al., 2009). All of these studies have consistently reported differ-
ential amygdala response in the s-allele carriers relative to l-allele
homozygotes.
Nonetheless, there is an active debate as to whether the differ-
ence in amygdala activation between s-carriers and l-homozygotes
is driven by increased activation of the amygdala to the emo-
tional stimuli themselves, an altered amygdala response at rest,
or a decreased response to neutral stimuli. Since functional imag-
ing studies are necessarily a contrast between two conditions, the
selection of a ‘baseline’ impacts highly on the conclusions that
can be drawn with respect to an observed effect. In their study
of 5-HTTLPR genotype and its effect on neural function, Canli et al.
(2005) suggested that the relative increase in amygdala activation
to emotional stimuli in s-carriers compared to l-homozygotes was
not due to hyperreactivity to emotional stimuli. Instead, they pro-
posed that itwas driven by a decreased activation to neutral stimuli
or an increased response to the ﬁxation condition in the s-carriers.
Their observationswerebasedon contrastswith aﬁxationbaseline,
where s-carriers displayed reduced activation to neutral stimuli
comparedwith ﬁxation. A follow-up study examining the effects of
gene by environment interactions as a function of serotonin trans-
porter genotype using perfusion imaging suggested that this effect
was actually driven by an increase in ‘rest’ activity in s-carriers
(Canli et al., 2006).
To further address this issue, Heinz et al. (2007) reanalysed the
data from their previous study (Heinz et al., 2005) with respect
to ﬁxation. They found a similar reduction in response to neutral
stimuli relative to ﬁxation. However, they suggested that while
this resulted from an increased response in s-carriers to the ﬁx-
ation condition, the effect should be ascribed to the heightened
anxiety associatedwith the ambiguity and uncertainty of a ﬁxation
condition. Thus, their interpretation would be in keeping with an
increased s-carrier response to negative or anxiogenic stimuli. Both
Canli et al. (2005) and Heinz et al. (2007) however had only neutral
and ﬁxation baseline conditions so the impact of ﬁxation could not
be assessed by contrasting it with a third independent baseline.
In light of these interpretations of 5-HTTLPR genotype action,
Canli and Lesch (2007) put forward two models of 5-HTT modula-
tion of amygdala activation (Fig. 1). The phasicmodel proposes that
the presence of the s-allele results in increased amygdala reactiv-
ity to emotional stimuli, whereas the tonicmodel proposes that the
differential amygdala activation in s-carriers and l-homozygotes is
driven by a baseline difference between the two groups such that
s-allele carriers display heightened amygdala activity compared to
non-carriers at rest (see Fig. 1).While Heinz et al.’s (2007) interpret
their data in terms of the phasic model, Canli et al.’s results (2005,
2006) support a primarily tonic model, but it is important to note
that the two models are not necessarily mutually exclusive. Two
further studies have since addressed the issue of a proposed tonic
baseline shift by examining the inﬂuence of 5-HTTLPR on resting
state activity and found increased perfusion of the amygdala in s-
carriers, providing support for a tonic baseline shift (Canli et al.,
2006; Rao et al., 2007). However, a more recent study, the largest
to date with 183 subjects, found no association between resting
blood perfusion in the amygdala and 5-HTTLPR genotype (Viviani
et al., 2010).
Here, we address these models by performing functional
imaging during an implicit negative emotional facial expression
Fig. 1. Schematic depiction of hypothesized amygdala activity in response to angry
and neutral facial expressions, as predicted by Canli & Lesch (2007), for the pha-
sic and tonic models of 5-HTTLPR-mediated amygdala responsivity. In the phasic
model, both s-carriers and l-homozygotes have a similar baseline and stimuli cause
an increase in amygdala activity. In the tonic model, the baseline for s-carriers has
been shifted up such that amygdala response to angry and neutral stimuli is now
reﬂected as a decrease with respect to the elevated baseline.
processing task with three ‘baseline’ conditions: neutral facial
expressions, houses andﬁxation.Wechose touse facial expressions
as a stimulus set because many studies have used facial expres-
sions in conjunction with the study of 5-HTTLPR, but the studies
discussing the tonic/phasic models have primarily used emotional
pictures or words (Canli et al., 2005; Heinz et al., 2007). Support for
the phasic model of the 5-HTTLPR polymorphism’s mechanism of
action would require an increased amygdala response in s-carriers
to negative emotional expressions regardless of baseline, with the
possible exception of ﬁxation if indeed it is an anxiogenic stimulus
as suggested by Heinz et al. (2007). Support for the tonic model
would require elevated baseline amygdala activity in s-carriers
which may manifest as a signiﬁcant reduction in amygdala acti-
vation for comparisons of neutral faces or houses with a ﬁxation
baseline andno signiﬁcantdifference in responsebetweennegative
facial expressions and ﬁxation (see Fig. 1).
2. Methods
2.1. Subjects
Sixty-eight healthy participants (23 male) with age range 20–41 years
(mean=31±6) participated in the study. Participantswere recruited from the Cam-
bridge BioResource, a large panel of volunteers that agreed to take part in research
linking genotype with phenotype (http://www.cambridgebioresource.org.uk/). All
volunteerswere right-handed European orNorthAmerican Caucasians. Participants
were subdivided into twogroups based on their 5-HTTLPR genotype,with one group
consistingof carriersof eitheroneor twos-alleles (n=45,meanage=30±6,17male)
and the other group consisting of l-allele homozygotes (n=23, mean age=31±6,
12 male). This grouping was based on previous observations that lymphoblasts
of carriers of either one or two copies of the s-allele had similar uptake levels
of 5-HTT, whereas l-allele homozygotes had twofold higher 5-HTT uptake (Lesch
et al., 1996). Previous functional imaging studies have also grouped homozygous
and heterozygous s-carriers together (Hariri et al., 2002; Passamonti et al., 2008).
The two groups did not signiﬁcantly differ in age (t(61) =0.22, p=0.83) or gender
(2(1,63) =0.32, p=0.57). Participants’ mental and physical health was screened
prior to genotyping using a detailedmedical history questionnaire used by the Cam-
bridge BioResource. This revealed no history of neurological disease or psychiatric
disorders, and no participants were on anymedication affecting the central nervous
system. All participants had normal or corrected to normal vision, and no structural
brain abnormalities were detected in their MRI scans. The study was approved by
the Cambridgeshire Local Research Ethics Committee, and all participants gave their
informed written consent. Participants also completed the Spielberger State-Trait
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Anxiety Inventory (STAI) (Spielberger, 1983) and had scores ranging from 20 to 49
(mean 32±7) for the State Anxiety scale and from 20 to 58 (mean 37±9) for the
Trait Anxiety scale. Three participants neglected to fully complete the Trait Anxiety
questionnaire but were nevertheless included in the imaging analysis. Neither the
State Anxiety nor the Trait Anxiety scores differed signiﬁcantly between the two
genotype groups (t(58) =0.22, p=0.73 and t(61) =0.35, p=0.83, respectively).
2.2. Genotyping
All subjects were genotyped for 5-HTTLPR. Samples were genotyped using
the Taqman 5 nuclease assay (Applied Biosystems, Warrington, UK) according to
the manufacturer’s protocol. DNA was extracted from blood samples obtained
from all subjects according to standard procedures. The 5-HTT regulatory gene
region was ampliﬁed by polymerase chain reaction (PCR) with the following
oligonucleotide primers: forward 5′-GGCGTTGCCGCTCTGAATGC-FAM -3′; reverse
5′-GAGGGACTGAGCTGGACAACCAC-3′ . PCR was performed with a ﬂuorescent label
for each sample and the fragment size measured on an ABI3730xl DNA Analyser
and scored using ABI genemapper software. To minimise error, two operators inde-
pendently scored the genotypes. The allele size and numbers of repeat sequences
observed were scored as follows: 485–16 Repeat (−44bp) (short); 529–16 Repeat
(long). Allele frequencies were 58% for the long and 42% for the short allele variant,
and genotype frequencies did not deviate from the Hardy–Weinberg equilibrium
with 34% l-l, 48% s-l, and 18% s-s (2 < 0.004, p=0.97, df = 1).
All subjects were also genotyped for catechol-O-methyl transferase (COMT),
since previous research found that a polymorphism in the COMT gene (val158met)
modulates amygdala response to emotional stimuli (Smolka et al., 2005).
The val158met COMT polymorphism was assayed by PCR ampliﬁcation using
the following primers: forward 5′-CCCAGCGGATGGTGGAT-3′ and reverse 5′-
CAGGCATGCACACCTTGTC-3′ . The ampliﬁcation conditions were initiated at 95 ◦C
for 10min, followed by 40 cycles consisting of denaturation at 92 ◦C for 15 s, and
annealing and extension at 60 ◦C for 1min. 24 participants were homozygous for
the met158 allele, 20 participants were homozygous for the val158 allele, and 24
participants were heterozygotes. There was no signiﬁcant association between the
5-HTTLPR and COMT genotypes (2 = 3.46, df = 4, p=0.50).
2.3. Stimuli
Facial stimuli consisted of grey-scale imageswith angry, sad and neutral expres-
sions selected from the NimStim Face Stimulus Set (Tottenham et al., 2009) and the
Karolinska directed emotional faces (KDEF) (Lundqvist & Litton, 1998) set based on
independent emotional ratings. There were 30 different identities (half female) for
each emotional expression. House stimuli consisted of grey-scale images of two-
or three-storey homes, all viewed from the front of the building. Stimuli were pre-
sented in a blocked design comprising eight 17.6s blocks of each of four conditions:
angry, sad, andneutral facial expressions, andhouses. Eachblock consistedof 4 stim-
uli presented for 4swith an ISI of 400ms. Participantswere instructed to respond by
buttonpresswhether the stimuluswas shiftedby0.5◦ to the left or right of the centre
of the screen. Each stimulus blockwas followed by 8s of ﬁxation, where participants
were instructed to passively view the ﬁxation cross at the centre of the screen. Gen-
der and identity of the faceswere fully randomized throughout the experiment, and
block order was presented in one of two pseudorandom orders. Reaction times and
accuracy were recorded. Total experiment duration was 13min and 40 s.
2.4. Functional imaging data acquisition and analysis
Whole-brain T2*-weighted echo-planar-imaging (EPI) was performed on a
Siemens 3T Tim Trio (32 slices, TR=2 s, TE =30ms, voxel size 3mm×3mm×3mm)
at the MRC Cognition & Brain Sciences Unit. The ﬁrst 4 scans were discarded
to allow for equilibration effects. Magnetization-prepared rapid-acquisition gra-
dient echo T1-weighted structural scans were also acquired in all subjects with
1mm×1mm×1mm resolution.
Imaging data were analysed using SPM5 (http://www.ﬁl.ion.ucl.ac.uk/spm). EPI
scans were corrected for slice timing differences and realigned to the ﬁrst func-
tional scan using rigid-body transformations to correct for headmovement. EPI and
structural images were coregistered and normalized to the T1 standard template
in MNI space (Montreal Neurological Institute (MNI)—International Consortium for
Brain Mapping) using linear and non-linear transformations, and smoothed with a
Gaussian kernel of full-width-half-maximum (FWHM) 8mm. Six participants (3 s-
carriers, 3 l-homozygotes)were removed fromtheanalysis followingpre-processing
due to gross movement during the scanning session (>2mm) (two participants) or
signal dropout in the medial temporal lobes (four participants).
Data were analysed using the general linear model as implemented in SPM5.
Condition effects were modelled using boxcar regressors convolved with a canoni-
cal hemodynamic response function. Spatial realignment parameterswere included
as regressors of no interest in the model to account for residual movement-related
variance. A high-pass ﬁlter at 128 s removed low-frequency signal drifts. Statisti-
cal parametric maps were generated for each individual by estimating activation
contrasts between all conditions (e.g. angry vs. neutral faces, sad faces vs. houses).
For each subject, data were extracted from the left and right amygdala using
an anatomical a priori amygdala region-of-interest derived from the Anatomical
Automatic Labelling (AAL) software (Tzourio-Mazoyer et al., 2002). Group differ-
ences in the amygdala response to emotional expressions were determined in SPSS
(SPSS Inc., Chicago, IL) with a repeated measures ANOVA in a group (s-carrier and l-
homozygotes; between subjects) by hemisphere (left and right; repeated measure)
by emotion (angry and sad; repeatedmeasure) design. Separate ANOVAs were con-
ducted for each of the 3 baseline conditions (e.g. emotion vs. neutral, emotion vs.
houses, emotion vs. ﬁxation). In addition, group differences across the baseline con-
ditionswere determined by contrasting the neutral facial expression conditionwith
aﬁxation or houses baseline, and contrastingﬁxationwith ahouses baseline in three
separate group by hemisphere repeated measure ANOVAs. Adjustment for multi-
ple comparisons was performed by Bonferroni correction and signiﬁcance levels
determined at p<0.05.Within each group, contrast estimates thatwere signiﬁcantly
different from zero were determined by one-sample t-tests.
3. Results
3.1. Behavioural results
There was no signiﬁcant difference between the s-carriers and
l-homozygotes in their ability to indicate the position of the stim-
uli on the screen. Both reaction times and accuracy (measured as
percent correct responses) were not signiﬁcantly different (reac-
tion times mean± SD: s-carriers =798±29ms, l-l = 815±43ms,
F(1,60) =0.11, p=0.74; percent correct: s-carriers =97±5%, l-
l = 96±6%, F(1,60) =0.65, p=0.43).
3.2. Functional imaging results
The extracted amygdala responses for the group analyses are
displayed in Fig. 2.
3.2.1. Emotion vs. neutral baseline
We found a signiﬁcant difference in bilateral amygdala activa-
tion between carriers of the s-allele and l-allele homozygotes in
response to angry and sad facial expressions compared to neutral
facial expressions (F(1,60) =6.77, p=0.01), with s-carriers display-
ing a greater response to emotional compared to neutral faces than
l-homozygotes (Fig. 2a). There was no signiﬁcant group by hemi-
sphere interaction (F(1,60) =0.30, p=0.59), however there was a
borderline group by emotion interaction (F(1,60) =2.91, p=0.09).
Despite the fact that the latter effect was not signiﬁcant, we broke
down this interaction to determine whether the difference in
amygdala response to emotion between the groups was more pro-
nounced for angry faces than for sad faces. Consistent with this
hypothesis, a pairwise corrected comparison revealed that there
was a signiﬁcant difference between the groups for the angry faces
condition (p=0.002) but not for the sad faces (p=0.13). Irrespective
of group, there was a signiﬁcantly greater amygdala response for
the comparison angry vs. neutral than sad vs. neutral facial expres-
sions (F(1,60) =7.77,p=0.007). Therewas also a signiﬁcant emotion
by hemisphere interaction (F(1,60) =5.46, p=0.02), reﬂecting a sig-
niﬁcantly greater response in the left hemisphere for angry vs.
neutral facial expressions but not for sad vs. neutral expressions.
3.2.2. Emotion vs. houses baseline
When emotional facial expressions were contrasted with a
houses baseline (Fig. 2b), s-carriers again displayed signiﬁcantly
greater response to emotional facial expressions than the l-
homozygotes (F(1,60) =4.39, p=0.04). Similar to the contrasts with
a neutral facial expression baseline, there was no signiﬁcant group
by hemisphere interaction (F(1,60) =0.59, p=0.45), but there was
a borderline group by emotion interaction (F(1,60) =2.92, p=0.09).
A pairwise comparison to break down this borderline interaction
again revealed that there was a signiﬁcant difference between the
two groups for the angry facial expression condition (p=0.009)
but not for the sad facial expression condition (p=0.24). Irre-
spective of group, there was a signiﬁcantly greater amygdala
response for the comparison angry faces vs. houses than sad
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Fig. 2. Extracted amygdala response from left and right hemisphere AAL regions-of-interest for s-allele carriers (grey shaded bars) and l-allele homozygotes (white bars)
for angry and sad facial expressions compared to (A) a neutral facial expressions baseline, (B) a houses baseline, and (C) a ﬁxation baseline. Contrasts across the baseline
conditions are shown in (D) for neutral facial expressions compared to ﬁxation, (E) for neutral facial expressions compared to houses, and (F) for houses compared to ﬁxation.
A ** represents a signiﬁcant (p<0.05) pairwise corrected group difference. A * indicates a parameter estimate signiﬁcantly (p<0.05) greater than 0. Error bars represent the
standard error of the mean. Coronal and sagittal sections depict the extent of the AAL regions-of-interest from which data were extracted.
faces vs. houses (F(1,60) =7.77, p<0.007). There was also a signif-
icant emotion by hemisphere interaction (F(1,60) =5.46, p=0.02),
reﬂecting a signiﬁcantly greater response in the left hemisphere for
angry facial expressions vs. houses but not for sad expressions vs.
houses.
3.2.3. Emotion vs. ﬁxation baseline
When the groups’ amygdala response to emotional facial
expressions were contrasted with a ﬁxation baseline (Fig. 2c),
there was no signiﬁcant group difference (F(1,60) =2.08, p=0.16)
between s-carriers and l-homozygotes. However, againwewanted
to investigate the effect of group on angry and sad faces sepa-
rately since we found a borderline group by emotion interaction
(F(1,60) =2.91, p=0.09). Pairwise corrected comparisons revealed
a signiﬁcant group difference for the angry facial expression con-
dition (p=0.04) but not for the sad facial expression condition
(p=0.66). Irrespective of group, there was a signiﬁcantly greater
amygdala response for the angry than for the sad facial expressions
contrasted with ﬁxation (F(1,60) =7.77, p=0.007). The hemisphere
by emotion interaction also achieved signiﬁcance (F(1,60) =5.46,
p=0.02), again reﬂecting a greater response in the left hemisphere
for angry facial expressions. There was no interaction between
group and hemisphere (F(1,60) =0.59, p=0.45).
3.2.4. Angry facial expressions only
When the difference between angry faces and each of the
three baseline conditions was compared across group in a separate
repeatedmeasuresANOVA, therewas a signiﬁcant groupdifference
across all conditions (F(1,60) =11.88,p=0.001) indicating that there
was a signiﬁcantly greater response in s-carriers to angry faces
regardless of baseline. Critically, there was no signiﬁcant group by
baseline interaction (F(1 =2,59) =0.69, p=0.50), indicating that the
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magnitude of the difference between angry faces and each of the
three baselines did not signiﬁcantly differ.
3.2.5. Baselines only
In order to address the tonic hypothesis,we compared amygdala
response across the different ‘baseline’ conditions. A comparison of
amygdala activation in the twogroups forneutral facial expressions
vs. ﬁxation baseline (F(1,60) =1.20, p=0.28) (Fig. 2d), and houses
vs. ﬁxation baseline (Fig. 2f; F(1,60) =0.81, p=0.37) showed no sig-
niﬁcant difference between groups. Similarly, a group comparison
for the contrasts neutral facial expressions compared to houses
(Fig. 2e; F(1,60) =0.06, p=0.81) was also not signiﬁcant.
3.2.6. Additional analyses
Since previous research has identiﬁed a polymorphism in the
COMT gene (val158met) as modulating amygdala response to emo-
tional stimuli (Smolka et al., 2005), all of our participants were
also genotyped for COMT and all analyses were repeated factor-
ing out COMT genotype. All group effects reported above remained
signiﬁcant (p’s < 0.05).
Although age and gender did not differ signiﬁcantly between
groups, we repeated all analyses with age and gender as covariates
in the ANOVAs. The outcome of the main effects remained similar.
Full statistics are included in Supplemental materials.
Despite the small number of s-allele homozygotes (12 partici-
pants), we also looked at the effects of allele load by breaking down
our analysis into threegroups: s-homozygotes (s-s), l-homozygotes
(l-l) and l-heterozygotes (s-l). Full details and statistics for this
analysis are found in Supplemental materials. Results should be
interpreted with caution however, as they may be underpowered
due to the small s-homozygote group.
Finally, we also performed a regression analysis between Spiel-
berger State andTraitAnxiety scores andamygdala activation for all
contrasts. We found no signiﬁcant association between amygdala
activation in s-carriers or l-homozygotes across anyof the contrasts
or baseline comparisons.
4. Discussion
We have shown that carriers of the s-allele variant of 5-HTTLPR
display heightened amygdala response relative to l-allele homozy-
gotes in response to emotional facial expressions. These results
therefore present further support for an effect of 5-HTTLPR on
amygdala function. In addition, through the use of three baseline
conditions, ahouses, aﬁxation, andaneutral facial expressions con-
dition, we found that the difference in amygdala response between
the groups is primarily driven by increased differential activity
of the amygdala to emotional stimuli rather than through altered
amygdala responseduringneutral stimulus conditionsor abaseline
resting difference in amygdala activity between the groups.
While both Canli et al. (2005) and Heinz et al. (2007) found
reduced amygdala activation in s-carriers to neutral words and
pictures compared to ﬁxation, we did not observe a signiﬁcant
reduction in s-carriers’ amygdala response to neutral facial expres-
sions. In fact, both groups displayed a statistically similar increase
in amygdala activation to neutral faces compared with both ﬁx-
ation and a houses baseline (Fig. 2d and e). A key difference
that distinguishes our study from the previous studies address-
ing the tonic-phasic hypotheses is our use of facial expressions as
a stimulus set. Single-cell recording has shown that the amygdala
contains face-responsive cells (Gothard, Battaglia, Erickson, Spitler,
&Amaral, 2007; Leonard, Rolls,Wilson,&Baylis, 1985) and thismay
explainwhy even neutral facial expressions engaged the amygdala,
an observation consistentwith previous research (Blasi et al., 2009;
Schwartz et al., 2003; Wright et al., 2003). Importantly however,
we observed no signiﬁcant difference between the groups in their
response to neutral facial expressions or houses relative to ﬁxation.
This is in contrast to the tonicmodelwhichpredicts that theposited
raised amygdala activity during rest (i.e., ﬁxation) in the s-carriers
should result in a signiﬁcant group difference for neutral faces or
houses in relation to ﬁxation.
Although Canli et al. (2006) used facial expressions as a stim-
ulus set in their gene by environment study, they did not report
the group contrasts alone but only their interaction with the envi-
ronment, so it is unclear whether or not they found an increased
or decreased response in the amygdala in s-carriers in response
to neutral faces compared with ﬁxation. Canli et al. (2005) used
affective words and Heinz et al. (2007) used affective pictures, but,
despite observing the same effect in both of their studies when
comparing ﬁxation with neutral stimuli, their respective interpre-
tations were different. While Heinz et al.’s (2007) interpretation is
in line with a phasic model of amygdala activation to negative or
anxiogenic stimuli, including aﬁxation condition, Canli et al. (2006)
and Canli & Lesch (2007) interpret the results as a tonic resting
amygdala activation difference between groups.
Our results provide greater support for a phasic model of amyg-
dala activation as a result of 5-HTTLPR genotype since we observed
signiﬁcantly increased amygdala response in s-carriers to emo-
tional facial expressions when compared with both a neutral faces
and a houses baseline condition. Although the group difference for
the contrast comparing emotional faces (angry and sad) with ﬁxa-
tion did not quite reach signiﬁcance, further exploration of the data
showedsigniﬁcantly increasedamygdala activation in s-carriers for
angry faces vs. ﬁxation. In addition, we found no signiﬁcant dif-
ference between the change in BOLD response between viewing
angry faces and each of the three baseline conditions (neutral faces,
houses, and ﬁxation), suggesting that the magnitude of the change
BOLD response to angry faces was not signiﬁcantly modulated by
baseline. Consistent with this, when the baselines were directly
contrasted with each other, we also found no signiﬁcant difference
between groups. Hence, we found no explicit support for the tonic
model in which the action of 5-HTTLPR on the amygdala is driven
by a passive resting baseline difference between the two groups
(Canli et al., 2006). Nonetheless, we do not wish to exclude a ‘tonic
contribution’ to our current data, particularly since the group dif-
ference between emotional faces andﬁxationwas less evident than
found relative to the neutral and house baselines. However, as sug-
gested by Heinz et al. (2007) this may reﬂect the anxiogenic nature
of the ﬁxation condition rather than a raised baseline per se.
Determining resting baseline differences however when con-
trasting ﬁxation with other conditions is contentious since activity
at ‘rest’ is not independently assessed by this sort of analysis but is
inferred with respect to another condition. To determine the pres-
ence of possible differences in resting baseline amygdala activity
underlying the tonic model, three studies have looked at rest-
ing blood perfusion in the amygdala. As already discussed, two
reported an association between s-carriers and relatively increased
perfusion of the amygdala (Canli et al., 2006; Rao et al., 2007), lend-
ing credence to the tonic hypothesis. However, a recent study by
Viviani et al. (2010), which looked at resting blood perfusion in a
large cohort of 183 individuals genotyped for 5-HTTLPR, found no
evidence for an effect of genotype on resting amygdala perfusion.
Further studieswill have to address resting amygdala differences to
resolve the discrepancy in these results. It is also important to point
out that the tonic andphasicmodels arenotmutually exclusive, and
that phasic activation tonegative stimuli in s-carriers couldoccur in
addition to a high baseline tonic activation. Our current results pro-
vide strong support for the phasic 5-HTTLPR-mediated amygdala
activation, where emotional stimuli cause brief bursts of increased
activation. Whether phasic-mediated effects might ride on top of
a tonic-mediated raised baseline under certain conditions remains
to be established, for instance in the case of a group of particularly
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high anxious s-carriers or in the case of gene by environment inter-
actions. Our current data however provide evidence for a primarily
phasic mediated response.
While the facial expression conditions and the houses condition
all had a task associatedwith them, the ﬁxation condition consisted
of passive viewing of the central ﬁxation cross. Thus,wemight have
expected the slightly stressful scanner environment to be brought
to the forefront during the ﬁxation condition and to preferentially
raise anxiety levels to some degree in carriers of the s-allele as sug-
gestedbyHeinz et al. (2007) – inparticular becauseourparticipants
were all novel to the scanner environment. However, although our
results support a largely phasic model of amygdala activation, we
found no signiﬁcant evidence for an effect of heightened anxiety
associated with the ﬁxation condition.
While the phasic model provides an interpretation for the
observed amygdala response associated with 5-HTTLPR, it is still
unclear exactly how this effect is mediated at the level of 5-
HTT action itself. Although research has suggested that a negative
association exists between amygdala response during an emotion
recognition task and 5-HTT availability in the amygdala, consistent
with the putative action of 5-HTTLPR, the polymorphism itself was
not assessed (Rhodes et al., 2007). Furthermore, a number of stud-
ies have failed to identify a signiﬁcant relationship between in vivo
bindingof5-HTT in thebrainands-allele carrier status (Parseyet al.,
2006; Shioe et al., 2003;Willeit et al., 2001), and two recent studies
in rhesus monkeys looking speciﬁcally at the availability of sero-
tonin transporter in the amygdala found no differences between
s-allele carriers and l-homozygotes (Christian et al., 2009; Jedema
et al., 2010). It seems therefore that while 5-HTTLPR clearly mod-
ulates amygdala responsivity to emotional stimuli, it may not do
so through direct action of 5-HTT in the amygdala itself. Future
research is required to fully elucidate the mechanisms underlying
amygdala hyperreactivity resulting from genetic variation in the
serotonin transporter gene.
It is worth noting thatmost previous studies of 5-HTTLPR action
on emotion processing in the amygdala have found a right lateral-
ized effect (Canli et al., 2005; Hariri et al., 2002; Heinz et al., 2005),
although this laterality was not explicitly addressed in these stud-
ies by comparing the left and right hemispheres. By contrast, we
have observed bilateral amygdala response to emotional faces but
no signiﬁcant interaction between group and hemisphere.
Finally, there are certain limitations to our study which should
be taken into consideration. Importantly, recent research has sug-
gested that a third functional allele, labelled LG, a single-nucleotide
polymorphism on the l-allele, is equivalent in expression to the s-
allele and may modulate effects of 5-HTTLPR at a biological and/or
behavioural level (Huet al., 2005;Zalsmanet al., 2006).As a result, it
is possible that our results may be affected by a further breakdown
of l-allele carriers into low and high expressing groups. However
the allelic frequency of LG in Caucasians is quite low (0.09–0.14)
(Hu et al., 2005) and would therefore likely only represent a very
small fraction of our participants. One further limitation relates
to our experimental design which was a pseudo-randomization
of experimental blocks with static ﬁxation blocks following every
experimental condition, hence increasing the predictability of the
ﬁxation condition. However, we chose this design deliberately to
keep our design as similar as possible toHeinz et al.’s (2007) design,
but increased the number of ﬁxation blocks relative to Canli et al.’s
(2005) study to increase the power.
4.1. Conclusions
In conclusion, we have shown that s-allele carriers display a
heightened amygdala response to negative facial expressions and
that this effect is driven primarily by an increased response to emo-
tional facial expressions rather thanadecreased response toneutral
faces or an elevated resting baseline alone. These results provide
further support for 5-HTTLPR-mediated amygdala modulation and
suggest that amygdala response to emotional faces in s-carriers
follows a phasic model of activation.
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